March 22, 2024

OncLive and Targeted Oncology covered research presented by the University of Cincinnati's Thomas Herzog that found patients with perivascular epithelioid sarcoma (PEComa) of gynecologic or peritoneal origin experienced rapid, durable responses when treated with the drug nab-sirolimus.

April 13, 2023

The University of Cincinnati's Amanda Jackson joined 55KRC's Simply Medicine program to discuss the UP-NEXT ovarian cancer clinical trial.

October 23, 2023

The University of Cincinnati Cancer Center's Leeya Pinder joined Local 12's What's Happening in Health to discuss her Cancer Moonshot Scholars research project focused on cervical cancer prevention for women living with HIV in Zambia.